ClinicalTrials.gg
Sign In

Otorhinolaryngologic Diseases clinical trials

The registry lists 63 studies for Otorhinolaryngologic Diseases across more than 10 countries. 9 are recruiting or about to start. 14 of them are mainly about Otorhinolaryngologic Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 73 narrower conditions too, such as Gastroesophageal Reflux: 9,331 studies, 2,033 open.

Get an email when these change. Save the Otorhinolaryngologic Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
38
Status unknown
7
Terminated
4
Recruiting
4
Active, not recruiting
4
Not yet recruiting
3

Phase

Phase 2
10
Phase 3
5
Phase 1
3
Phase 4
2

Where

United States
21
France
7
Germany
5
Canada
5
Poland
4
Denmark
3

Who runs them

Advanced Bionics (7) · Otic Pharma (3) · Oregon Health and Science University (3) · Oticon Medical (2) · Assistance Publique - Hôpitaux de Paris (2) · Centre Hospitalier Universitaire de Besancon (1) · Otonomy, Inc. (1) · University of Alberta (1)

What is being tested here

Drugs under test in Otorhinolaryngologic Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin101
Carboplatin101
Brimapitide022
Ciprofloxacin002
Verekitug001
Dexamethasone011
Sustained-Exposure Dexamethasone Formulation OTO-104011
Benralizumab011
Ibuprofen001
Everolimus001

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 4 Otorhinolaryngologic Diseases studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 1 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
AgeWomenMen
101 (25%)1 (25%)
183 (75%)3 (75%)
303 (75%)3 (75%)
403 (75%)3 (75%)
503 (75%)3 (75%)
653 (75%)3 (75%)
753 (75%)3 (75%)
853 (75%)3 (75%)

Across all 63 studies, recruiting or not: 25% stop at 75 or younger and 21% at 65; 33% take children; 0% are for women only and 2% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Otorhinolaryngologic Diseases studies take

Of 20 interventional studies with no phase under Otorhinolaryngologic Diseases, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo13–43 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 → or search them.